GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
69.82
+1.15 (1.67%)
At close: Jun 26, 2026, 4:00 PM EDT
68.70
-1.12 (-1.60%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Company Description
GeneDx Holdings Corp., a genomics company, provides genetic testing services.
The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp.
| Country | United States |
| Founded | 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 1,300 |
| CEO | Katherine Stueland |
Contact Details
Address: North Tower, 6th Floor Stamford, Connecticut 06902 United States | |
| Phone | 888 729 1206 |
| Website | genedx.com |
Stock Details
| Ticker Symbol | WGS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001818331 |
| CUSIP Number | 81663L200 |
| ISIN Number | US81663L2007 |
| Employer ID | 85-1966622 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Kevin Feeley CPA | Chief Financial Officer |
| Dr. Bryan M. Dechairo Ph.D. | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 23, 2026 | 8-K | Current Report |
| Jun 16, 2026 | 8-K | Current Report |
| May 22, 2026 | SCHEDULE 13D/A | Filing |
| May 15, 2026 | SCHEDULE 13D/A | Filing |
| May 11, 2026 | SCHEDULE 13D/A | Filing |
| May 4, 2026 | 10-Q | Quarterly Report |
| May 4, 2026 | 8-K | Current Report |
| Apr 30, 2026 | ARS | Filing |
| Apr 30, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 30, 2026 | DEF 14A | Other definitive proxy statements |